Citigroup Boosts Xylem (NYSE:XYL) Price Target to $139.00

Xylem (NYSE:XYL - Get Free Report) had its target price boosted by equities research analysts at Citigroup from $126.00 to $139.00 in a note issued to investors on Monday, Benzinga reports. The firm currently has a "neutral" rating on the industrial products company's stock. Citigroup's target price would indicate a potential upside of 7.81% from the stock's previous close.

Other equities research analysts also recently issued research reports about the stock. BNP Paribas started coverage on shares of Xylem in a research note on Tuesday, March 12th. They set an "outperform" rating and a $150.00 price target on the stock. Stifel Nicolaus upped their price target on shares of Xylem from $136.00 to $150.00 and gave the company a "buy" rating in a research note on Wednesday, February 7th. Raymond James upgraded shares of Xylem from an "underperform" rating to a "market perform" rating in a research report on Thursday, January 4th. Royal Bank of Canada boosted their price objective on shares of Xylem from $140.00 to $145.00 and gave the company an "outperform" rating in a research report on Wednesday, February 7th. Finally, Wolfe Research started coverage on shares of Xylem in a research report on Wednesday, December 13th. They set an "outperform" rating and a $127.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $135.44.

Xylem Price Performance

NYSE:XYL traded up $1.18 during trading hours on Monday, hitting $128.93. 739,410 shares of the stock traded hands, compared to its average volume of 1,154,012. Xylem has a 1 year low of $87.59 and a 1 year high of $130.86. The stock has a 50 day moving average price of $125.52 and a 200 day moving average price of $110.58. The company has a quick ratio of 1.30, a current ratio of 1.76 and a debt-to-equity ratio of 0.22. The company has a market cap of $31.25 billion, a price-to-earnings ratio of 47.40, a price-to-earnings-growth ratio of 2.55 and a beta of 1.10.

Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Tuesday, February 6th. The industrial products company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.96 by $0.03. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The firm had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.05 billion. During the same quarter in the previous year, the firm earned $0.92 earnings per share. The company's quarterly revenue was up 40.6% compared to the same quarter last year. Sell-side analysts forecast that Xylem will post 4.13 EPS for the current fiscal year.

Insider Buying and Selling at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the sale, the chief accounting officer now directly owns 2,935 shares of the company's stock, valued at $360,682.15. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now directly owns 11,750 shares of the company's stock, valued at approximately $1,431,032.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the transaction, the chief accounting officer now directly owns 2,935 shares of the company's stock, valued at $360,682.15. The disclosure for this sale can be found here. Insiders own 0.90% of the company's stock.

Hedge Funds Weigh In On Xylem

Hedge funds and other institutional investors have recently modified their holdings of the stock. Bruce G. Allen Investments LLC acquired a new position in Xylem in the 4th quarter worth approximately $27,000. NBC Securities Inc. acquired a new position in Xylem in the 3rd quarter worth approximately $38,000. KB Financial Partners LLC acquired a new position in Xylem in the 1st quarter worth approximately $42,000. Coppell Advisory Solutions LLC acquired a new position in Xylem in the 2nd quarter worth approximately $45,000. Finally, ST Germain D J Co. Inc. acquired a new position in Xylem in the 2nd quarter worth approximately $46,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.